1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ZIM LABORATORIES LTD.
Zim Laboratories Ltd.
NSE: ZIMLAB | BSE: 541400
138.57 1.47 (1.07%)
69,462
NSE+BSE Volume

NSE 06 Oct, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert



Board Meetings - Zim Laboratories

The latest board meeting for Zim Laboratories took place on 06 Aug 2026, for the purpose of Quarterly Results

Ex-date Purpose Notes
06 Aug 2026 Quarterly Results -
19 May 2026 Audited Results -
11 Feb 2026 Quarterly Results -
21 Jan 2026 Others -
12 Nov 2025 Quarterly Results -
07 Aug 2025 Quarterly Results -
20 May 2025 Audited Results -
10 Feb 2025 Quarterly Results -
09 Nov 2024 Quarterly Results -
03 Aug 2024 Quarterly Results -
13 May 2024 Audited Results -
29 Jan 2024 Quarterly Results -
01 Nov 2023 Quarterly Results -
14 Aug 2023 Quarterly Results -
19 May 2023 Audited Results -
03 Feb 2023 Quarterly Results -
12 Nov 2022 Quarterly Results & Bonus issue -
26 Jul 2022 Quarterly Results -
21 May 2022 Audited & Quarterly Results -
31 Jan 2022 Quarterly Results -
30 Oct 2021 Quarterly Results -
13 Aug 2021 Quarterly Results -
29 May 2021 Audited Results -
11 Feb 2021 Quarterly Results -
26 Oct 2020 Quarterly Results -
04 Aug 2020 Quarterly Results -
02 Jun 2020 Audited Results -
04 Feb 2020 Quarterly Results -
11 Nov 2019 Quarterly Results -
06 Aug 2019 Quarterly Results -
22 May 2019 Audited Results & Dividend -
09 Apr 2019 Others Inter alia, to consider and approve the proposal for allotment of Secured, Redeemable Non-convertible Debentures for Rs. 35.00 Crore to UTI Structured Debt Opportunities Fund 1.
22 Feb 2019 Others Inter alia, 1. Convening the Extra Ordinary General Meeting for obtaining shareholders approval for fund raising through issue of Unsecured, Unlisted, Redeemable, Non-Convertible Debentures.
06 Feb 2019 Quarterly Results -
04 Nov 2018 Quarterly Results -
14 Aug 2018 Quarterly Results, Dividend & Bonus -